Efficacy and safety of early prone positioning combined with HFNC or NIV in moderate to severe ARDS: a multi-center prospective cohort study

Table 1 Clinical characteristics and outcomes of patients in the success group

Case No.	Gender	Age (yo)	Cause of ARDS	Baseline PaO₂/FiO₂ (mmHg)	SpO₂ (%)	PaO₂/FiO₂ with HFNC	PaO₂/FiO₂ with HFNC+PP	PaO₂/FiO₂ with NIV	PaO₂/FiO₂ with NIV+PP	Intubation	ECMO	Outcome
1	Male	43	Influenza	160	95	108	144	160		No	No	Survive
2	Male	49	Pneumonia without pathogen	109	93		108	109	152	No	No	Survive
3	Male	37	Viral Pneumonia	117	95	59	87	117		No	No	Survive
4	Male	61	Pneumonia without pathogen	170	96	115	168	170		No	No	Survive
5	Male	43	Influenza	141	93			141	173	No	No	Survive
6	Male	56	Influenza	142	95	94	100	142		No	No	Survive
7	Female	54	Influenza		92	99	151			No	No	Survive
8	Male	30	Pneumonia without pathogen	168	96			168	174	No	No	Survive
9	Male	40	Pneumonia without pathogen	167	96			167	90	No	No	Survive
10	Female	54	Pneumonia without pathogen	63	95		63		150	No	No	Survive
11	Female	48	Influenza	237	96		178	237		No	No	Survive

ARDS acute respiratory distress syndrome, NIV non-invasive ventilation, HFNC high flow nasal cannula, PP prone position, ECMO extracorporeal membrane oxygenation

ISSN: 1364-8535